InvestorsHub Logo
Followers 3
Posts 253
Boards Moderated 0
Alias Born 08/23/2007

Re: Maps0117 post# 8797

Saturday, 03/24/2018 3:40:44 PM

Saturday, March 24, 2018 3:40:44 PM

Post# of 9747
Possible takeover reasons...

Three Phase 3 assets, two with data readout next year
Cutaneous T-cell lymphoma (SGX301)
Pivotal study in progress with results expected 1H 2019
Oral mucositis in head & neck cancer (SGX942)
Pivotal study in progress with results expected 2H 2019
Pediatric Crohn’s disease (SGX203)
Pivotal study targeted to begin 2H 2018, contingent upon additional funding
and/or partnership

Go SNGX
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNGX News